Alisa Likhitsup, MD, MPH
Clinical Assistant Professor of Internal Medicine
[email protected]

Available to mentor
Alisa Likhitsup, MD, MPH
Clinical Assistant Professor
  • About
  • Qualifications
  • Recent Publications
    • About

    Dr. Likhitsup is board-certified in gastroenterology and transplant hepatology and committed to care for patients with chronic liver diseases, viral hepatitis, fatty liver, cirrhosis, liver failure, liver cancer, and liver transplantation.

    Qualifications
    • Transplant Hepatology Fellowship
      University of Michigan–Ann Arbor, Ann Arbor, 2018
    • Gastroenterology Fellowship
      University of Missouri–Kansas City, Kansas City, 2017
    • Internal Medicine Resident
      University of Missouri–Kansas City, Kansas City, 2014
    • Master of Public Health (Epidemiology)
      Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 2022
    • MD
      Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2008
    Recent Publications See All Publications
    • Journal Article
      Diagnosis and management of immune mediated liver injury from checkpoint inhibitors.
      Likhitsup A, Fontana RJ. Curr Opin Gastroenterol, 2024 May 1; 40 (3): 164 - 171. DOI:10.1097/MOG.0000000000001015
      PMID: 38375823
    • Journal Article
      Outcomes and Predictors of 30-Day Readmission in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization between 2016 and 2018
      Fatima I, Ahmed M, Mohamed WT, Jahagirdar V, Kennedy KF, Likhitsup A. Gastroenterology Insights, 2024 Mar 1; 15 (1): 87 - 97. DOI:10.3390/gastroent15010006
    • Journal Article
      Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma.
      Fatima I, Parikh ND, Likhitsup A. Surg Oncol Clin N Am, 2024 Jan; 33 (1): 43 - 58. DOI:10.1016/j.soc.2023.06.007
      PMID: 37945144
    • Presentation
      Autoimmune, Metabolic, and Drug Induced Liver Disease, 26th Annual Liver Disease Wrap-Up
      Likhitsup A. 2023 Dec 9;
    • Presentation
      Population level exposure estimates to 4 potentially hepatotoxic HDS botanical products: Results from the NHANES 2017-2018 cohort.
      Likhitsup A. 2023 Nov;
    • Presentation
      What's New in Primary Sclerosing Cholangitis and Primary Biliary Cholangitis, 12th Annual Western Michigan Liver Round-Up
      Likhitsup A. 2023 Oct 27;
    • Proceeding / Abstract / Poster
      FRI-422 Diabetes increases risk of mortality in alcohol-related liver disease
      Theodoreson M, Aithal G, Allison M, Brahmania M, Forrest E, Hagström H, Likhitsup A, Masson S, McCune A, Rajoriya N, Rowe I, Parker R. Journal of Hepatology, 2023 Jun; 78: s157 - s158. DOI:10.1016/s0168-8278(23)00669-4
    • Proceeding / Abstract / Poster
      SAT-437 The prevalence and predictors of non-alcoholic fatty liver disease by vibration controlled transient elastography among lean adults in the United States
      Fatima I, Ahmed M, Mohamed W, Likhitsup A. Journal of Hepatology, 2023 Jun; 78: s678 - s679. DOI:10.1016/s0168-8278(23)02043-3